523 related articles for article (PubMed ID: 10468620)
1. Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity.
Meng L; Mohan R; Kwok BH; Elofsson M; Sin N; Crews CM
Proc Natl Acad Sci U S A; 1999 Aug; 96(18):10403-8. PubMed ID: 10468620
[TBL] [Abstract][Full Text] [Related]
2. Total synthesis of the potent proteasome inhibitor epoxomicin: a useful tool for understanding proteasome biology.
Sin N; Kim KB; Elofsson M; Meng L; Auth H; Kwok BH; Crews CM
Bioorg Med Chem Lett; 1999 Aug; 9(15):2283-8. PubMed ID: 10465562
[TBL] [Abstract][Full Text] [Related]
3. Towards subunit-specific proteasome inhibitors: synthesis and evaluation of peptide alpha',beta'-epoxyketones.
Elofsson M; Splittgerber U; Myung J; Mohan R; Crews CM
Chem Biol; 1999 Nov; 6(11):811-22. PubMed ID: 10574782
[TBL] [Abstract][Full Text] [Related]
4. The selective proteasome inhibitors lactacystin and epoxomicin can be used to either up- or down-regulate antigen presentation at nontoxic doses.
Schwarz K; de Giuli R; Schmidtke G; Kostka S; van den Broek M; Kim KB; Crews CM; Kraft R; Groettrup M
J Immunol; 2000 Jun; 164(12):6147-57. PubMed ID: 10843664
[TBL] [Abstract][Full Text] [Related]
5. Specificities of cell permeant peptidyl inhibitors for the proteinase activities of mu-calpain and the 20 S proteasome.
Mellgren RL
J Biol Chem; 1997 Nov; 272(47):29899-903. PubMed ID: 9368065
[TBL] [Abstract][Full Text] [Related]
6. Role of the proteasome and NF-kappaB in streptococcal cell wall-induced polyarthritis.
Palombella VJ; Conner EM; Fuseler JW; Destree A; Davis JM; Laroux FS; Wolf RE; Huang J; Brand S; Elliott PJ; Lazarus D; McCormack T; Parent L; Stein R; Adams J; Grisham MB
Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15671-6. PubMed ID: 9861028
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin.
Fenteany G; Standaert RF; Lane WS; Choi S; Corey EJ; Schreiber SL
Science; 1995 May; 268(5211):726-31. PubMed ID: 7732382
[TBL] [Abstract][Full Text] [Related]
8. Kinetic studies of the branched chain amino acid preferring peptidase activity of the 20S proteasome: development of a continuous assay and inhibition by tripeptide aldehydes and clasto-lactacystin beta-lactone.
McCormack TA; Cruikshank AA; Grenier L; Melandri FD; Nunes SL; Plamondon L; Stein RL; Dick LR
Biochemistry; 1998 May; 37(21):7792-800. PubMed ID: 9601040
[TBL] [Abstract][Full Text] [Related]
9. Proteasome inhibition by the natural products epoxomicin and dihydroeponemycin: insights into specificity and potency.
Kim KB; Myung J; Sin N; Crews CM
Bioorg Med Chem Lett; 1999 Dec; 9(23):3335-40. PubMed ID: 10612595
[TBL] [Abstract][Full Text] [Related]
10. Synthetic inhibitors of the multicatalytic proteinase complex (proteasome).
Wilk S; Figueiredo-Pereira ME
Enzyme Protein; 1993; 47(4-6):306-13. PubMed ID: 7697128
[TBL] [Abstract][Full Text] [Related]
11. The antitumor drug aclacinomycin A, which inhibits the degradation of ubiquitinated proteins, shows selectivity for the chymotrypsin-like activity of the bovine pituitary 20 S proteasome.
Figueiredo-Pereira ME; Chen WE; Li J; Johdo O
J Biol Chem; 1996 Jul; 271(28):16455-9. PubMed ID: 8663210
[TBL] [Abstract][Full Text] [Related]
12. Glutathiolation of the proteasome is enhanced by proteolytic inhibitors.
Demasi M; Shringarpure R; Davies KJ
Arch Biochem Biophys; 2001 May; 389(2):254-63. PubMed ID: 11339815
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the chymotrypsin-like activity of the pituitary multicatalytic proteinase complex.
Vinitsky A; Michaud C; Powers JC; Orlowski M
Biochemistry; 1992 Oct; 31(39):9421-8. PubMed ID: 1356435
[TBL] [Abstract][Full Text] [Related]
14. How an inhibitor of the HIV-I protease modulates proteasome activity.
Schmidtke G; Holzhütter HG; Bogyo M; Kairies N; Groll M; de Giuli R; Emch S; Groettrup M
J Biol Chem; 1999 Dec; 274(50):35734-40. PubMed ID: 10585454
[TBL] [Abstract][Full Text] [Related]
15. Specific inhibition of the chymotrypsin-like activity of the proteasome induces a bipolar morphology in neuroblastoma cells.
Fenteany G; Schreiber SL
Chem Biol; 1996 Nov; 3(11):905-12. PubMed ID: 8939705
[TBL] [Abstract][Full Text] [Related]
16. Structural investigation of proteasome inhibition.
Ditzel L; Stock D; Löwe J
Biol Chem; 1997; 378(3-4):239-47. PubMed ID: 9165077
[TBL] [Abstract][Full Text] [Related]
17. Components of the bovine pituitary multicatalytic proteinase complex (proteasome) cleaving bonds after hydrophobic residues.
Cardozo C; Michaud C; Orlowski M
Biochemistry; 1999 Jul; 38(30):9768-77. PubMed ID: 10423257
[TBL] [Abstract][Full Text] [Related]
18. Differential inhibition of calpain and proteasome activities by peptidyl aldehydes of di-leucine and tri-leucine.
Tsubuki S; Saito Y; Tomioka M; Ito H; Kawashima S
J Biochem; 1996 Mar; 119(3):572-6. PubMed ID: 8830056
[TBL] [Abstract][Full Text] [Related]
19. Involvement of proteasome in endothelin-1 production in cultured vascular endothelial cells.
Ohkita M; Takaoka M; Kobayashi Y; Itoh E; Uemachi H; Matsumura Y
Jpn J Pharmacol; 2002 Feb; 88(2):197-205. PubMed ID: 11928721
[TBL] [Abstract][Full Text] [Related]
20. Purification and characterization of a protein inhibitor of the 20S proteasome (macropain).
Chu-Ping M; Slaughter CA; DeMartino GN
Biochim Biophys Acta; 1992 Mar; 1119(3):303-11. PubMed ID: 1312359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
